
Dabipack 110mg Capsule
Marketer
Koye Pharmaceuticals Pvt ltd
Salt Composition
Dabigatran Etexilate (110mg)
Overview Dabipack 110mg Capsule
Anticoagulant therapy with 110mg Dabipack capsules helps prevent and manage blood clots, lowering the risk of stroke and heart attack. This medication inhibits clot formation in leg, lung, brain, and heart veins. Frequently prescribed for patients with atrial fibrillation to prevent thrombus formation, it's also used post-knee or hip replacement surgery. Dabipack 110mg can be taken with or without food, but consistent daily timing is recommended. Long-term, even lifelong, use may be necessary; discontinuation or dosage alterations should only occur under medical supervision to avoid increased stroke, heart attack, or thrombosis risk. Lifestyle modifications such as healthy eating, exercise, weight management, and smoking cessation can further minimize clot risk. Common side effects include gastrointestinal upset and increased bleeding tendency (e.g., nosebleeds, bruising). Report any adverse effects promptly. Additional potential side effects encompass headaches, seizures, allergic reactions, visual disturbances, and fatigue. Contraindications include severe hepatic or renal impairment, active bleeding, and concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR monitoring isn't needed.
Uses of Dabipack 110mg Capsule
Managing and averting blood clot formation
Major Benefits of Dabipack 110mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dabipack 110mg Capsules can be ingested with or without food; however, consistent daily timing is recommended.
Common Side effects of Dabipack 110mg Capsule:
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Dabipack 110mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dabipack 110mg Capsules can be administered with or without food; however, consistent timing is recommended.
How Dabipack 110mg Capsule works:
Edoxaban 110mg capsules represent a new generation of oral blood thinners. Their mechanism of action involves inhibiting blood clot development.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Dabipack 110mg Capsules is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dabipack 110mg Capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Using Dabipack 110mg capsules while breastfeeding is likely unsafe. Available data from humans indicates potential transfer of the medication to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Dabipack 110mg Capsules.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Dabipack 110mg Capsules, as dosage modification may be necessary. Consult a physician before use; Dabipack 110mg Capsules are generally not advised for those with severe kidney disease.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Dabipack 110mg capsules. Dosage modification may be necessary. A physician's advice is recommended.
What if you forget to take Dabipack 110mg Capsule :
Should you forget a Dabipack 110mg Capsule dose, ingest it immediately, provided it's still the same day. However, omit the missed dose if taking it is impossible within six hours of your next scheduled dose. Never compensate for a missed dose by doubling up on medication.
Facts to Know About Dabipack 110mg Capsule
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Oral direct thrombin inhibitor |
